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Background: The transcription factor Pax8 is expressed during thyroid development and is involved in the
morphogenesis of the thyroid gland and maintenance of the differentiated phenotype. In particular, Pax8 has been
shown to regulate genes that are considered markers of thyroid differentiation. Recently, the analysis of the gene
expression profile of FRTL-5 differentiated thyroid cells after the silencing of Pax8 identified Wnt4 as a novel target.
Like the other members of the Wnt family, Wnt4 has been implicated in several developmental processes including
regulation of cell fate and patterning during embryogenesis. To date, the only evidence on Wnt4 in thyroid
concerns its down-regulation necessary for the progression of thyroid epithelial tumors.
Results: Here we demonstrate that Pax8 is involved in the transcriptional modulation of Wnt4 gene expression
directly binding to its 5’-flanking region, and that Wnt4 expression in FRTL-5 cells is TSH-dependent. Interestingly,
we also show that in thyroid cells a reduced expression of Wnt4 correlates with the alteration of the epithelial
phenotype and that the overexpression of Wnt4 in thyroid cancer cells is able to inhibit cellular migration.
Conclusions: We have identified and characterized a functional Pax8 binding site in the 5’-flanking region of the
Wnt4 gene and we show that Pax8 modulates the expression of Wnt4 in thyroid cells. Taken together, our results
suggest that in thyroid cells Wnt4 expression correlates with the integrity of the epithelial phenotype and is
reduced when this integrity is perturbed. In the end, we would like to suggest that the overexpression of Wnt4 in
thyroid cancer cells is able to revert the mesenchymal phenotype.
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Wnts are powerful regulators of cell proliferation and
differentiation, and their signaling pathway involves pro-
teins that directly participate in both gene transcription
and cell adhesion [1]. Over the past two decades, 19
members of the Wnt protein family have been found in
mammals and have been subdivided into canonical
signaling, with transforming activities in mammary epi-
thelial cells, and non canonical signaling involved in the
planar cell polarity (PCP) and in Calcium signaling [2].
Member of the Wnt family, Wnt4 is classified as a non-
canonical Wnt protein even though there is evidence
that it is also able to activate the canonical signaling* Correspondence: s.zannini@ieos.cnr.it
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unless otherwise stated.pathway [3]. Wnt4 knockdown highlighted its crucial role
in the development of several organs such as kidney, ovary
and mammary gland [4,5]. Moreover, Wnt4 null mice die
within 24 h of birth, probably because of severe lack of kid-
ney functions [6]. In fact, during kidney development Wnt4
plays a key role in the mesenchymal to epithelial transition
and in the morphogenesis required for tubule formation
[7], and its expression is regulated by the transcription fac-
tor Pax2 [8]. Interestingly, in humans defects in WNT4 are
a cause of Rokitansky-Kuster-Hauser syndrome (RKH syn-
drome) characterized by utero-vaginal atresia in otherwise
phenotypically normal female with a normal 46,XX karyo-
type [9]. Homozygous null mutation in WNT4 is the cause
of female sex reversal with dysgenesis of kidneys, adrenals,
and lungs (SERKAL syndrome), demonstrating that this
gene plays an essential role in human sex-determination
and organogenesis [10]. Furthermore, mutations in theal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ian dysfunction [11].
Recently, Wnt4 was shown to be strongly down-
regulated in human anaplastic carcinomas and to behave
as a key factor in Ras-mediated transformation of rat epi-
thelial cells [12]. In addition, the analysis of the gene ex-
pression profile of FRTL-5 differentiated thyroid cells after
the silencing of the transcription factor Pax8 identified
Wnt4 among the down-regulated genes and by ChIP assay
Wnt4 was defined as a novel direct target of Pax8 [13].
Pax8, a member of the Pax genes family, was shown to
be required for both morphogenesis of the thyroid gland
[14] and maintenance of the thyroid differentiated pheno-
type [15]. Interestingly, mutations in the Pax8 gene have
been associated with congenital hypothyroidism in humans
[16-19]. During the embryogenesis Pax8 is expressed not
only in the thyroid but also in other tissues such as the
metanephros, the midhindbrain boundary region [20,21], as
well as in the Müllerian duct [5]. In Pax8 knockout mice,
the thyroid gland is barely visible and lacks the follicular
cells; accordingly, the expression of the thyroid-specific
markers thyroglobulin and thyroperoxidase cannot be de-
tected in line with the crucial role that Pax8 plays in thyro-
cytes differentiation [14]. Moreover, as a consequence of
their athyroidism, Pax8 deficient mice are deaf, growth re-
tarded, ataxic, and do not survive weaning. As in most
cases of congenital hypothyroid patients, in Pax8-deficient
mice the symptoms can be reversed by the TH replacement
therapy if instituted within the first days of postnatal life
[22,23]. It is of interest to note that Pax8−/− mice that were
properly substituted with TH and developed otherwise nor-
mally without any overt deficits did not become fertile [24].
Indeed, the analysis of the male and female reproductive
system demonstrated that the Pax8−/− mice fail to develop
correctly [25].
Here, we investigated the involvement of Pax8 in the
regulation of Wnt4 gene expression in thyroid cells. The
in silico analysis of the 5’-flanking region of the Wnt4
gene identified several putative Pax8 binding sites and
our data here reported show that indeed Pax8 is in-
volved in the transcriptional regulation of the Wnt4
gene. All together, our results indicate that in thyroid
cells Pax8 participates to Wnt4 gene expression directly
binding to its 5′-flanking region and that a reduced ex-
pression of Wnt4 correlates with the alteration of the
epithelial phenotype. Moreover, we also show that the
overexpression of Wnt4 in thyroid cancer cells is able to
inhibit cellular migration.
Results
Wnt4 expression in thyroid cells is modulated by TSH
In the past, we observed that in FRTL-5 cells cultured in
the absence of TSH, Pax8 mRNA and protein rapidly
disappear, whereas upon TSH stimulation, both mRNAand protein are newly synthesized [26]. To investigate
the role of TSH in Wnt4 expression, FRTL-5 cells were
starved for 4 days in 0.2% calf serum-medium and sub-
sequently treated with TSH for 24 hours. The expression
of both Pax8 and Wnt4 was analyzed at the protein level
by immunofluorescence. As expected, Pax8 expression is
strongly reduced upon starvation of the cells and rein-
duced upon TSH stimulation. Similarly, also the expres-
sion of Wnt4 turned out to be modulated by TSH in a
way that well correlates with Pax8 expression profile
suggesting that TSH regulation of Wnt4 expression
could be mediated by Pax8 (Figure 1A).
Previous studies associated Wnt proteins with glycos-
aminoglycans in the extracellular matrix and bound
tightly to the cell surface [27-29]. Beyond this informa-
tion, the localization of Wnt proteins in vertebrates re-
mains unclear. The immunofluorescence experiment in
Figure 1A allowed us to obtain information also on the
subcellular distribution of the Wnt4 protein in thyroid
cells, showing the presence of Wnt4 exclusively in the
cytoplasmic compartment of this cell type.
To better clarify whether TSH stimulation of Wnt4 ex-
pression is entirely mediated by Pax8, we performed a
Pax8 knock-down experiment. In details, FRTL-5 thyroid
cells were transfected with siGENOME Pax8 siRNA (ex-
perimental) or siGENOME Non-Targeting siRNA (con-
trol), a scrambled sequence that does not show homology
with any rat gene. Few hours after transfection, cells were
starved in 0.2% calf serum medium for 24 hours and then
stimulated for 3 hours with TSH. The expression of both
Pax8 and Wnt4 was analyzed at the mRNA level by qRT-
PCR. Interestingly, when Pax8 is inhibited by the silen-
cing, the stimulation with TSH does not induce high levels
of Wnt4 as it happens in the siCtrl- sample (Figure 1B).
This result supports the hypothesis that a significant frac-
tion of Wnt4 response to TSH stimulation is indeed medi-
ated by Pax8.
The 5′-flanking region of the Wnt4 gene is responsive
to Pax8
To determine whether Pax8 could regulate Wnt4 gene ex-
pression by directly binding to its regulatory genomic se-
quence, we performed a computational analysis using the
MatInspector Software 8.0. We searched for Pax8 binding
sites in a region of about 3 Kb in the Wnt4 5′-flanking re-
gion and the analysis showed the presence of several Pax8
binding sequences.
To characterize more in detail the genomic region up-
stream the Wnt4 gene and to assess its transcriptional
activity in thyroid cells, five different fragments corre-
sponding to progressive deletions of the 5′-flanking re-
gion were subcloned in the pGL3-basic vector upstream
the luciferase reporter gene. All the deletions were engi-
neered taking into account the position of the Pax8
Figure 1 Wnt4 is localized in the cytoplasmic compartment of FRTL-5 cells and its expression is modulated by TSH. A) Wnt4 expression
is modulated by TSH in FRTL-5 thyroid cells. FRTL-5 cells were cultured in regular medium or in starvation medium for 4 days (0.2% CS) and
treated with 1 mU/ml of TSH for 24 h, and analyzed by immunofluorescence to detect Pax8 and Wnt4 proteins with specific antibodies (see
Methods). B) TSH stimulation of Wnt4 expression is mediated by Pax8. FRTL-5 cells were cultured in regular medium and transfected with 100 nM
of siPax8 or siCtrl-. Seven hours later, cells were starved in 0.2% CS medium for 24 h and treated with 1 mU/ml of TSH for 3 h and analyzed by
qRT-PCR to measure the expression levels of Pax8 (black bars) and Wnt4 (gray bars) mRNAs. Data are from three independent experiments, each
performed in duplicate and are expressed as the mean ± SD (P < 0,1).
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(Figure 2A).
To verify the transcriptional activity of each fragment,
the deletion constructs were transiently transfected in
FRTL-5 thyroid cells and in HeLa cells, the latter negative
for the expression of Pax8. The results obtained demon-
strate that all the constructs have a high transcriptional
activity in thyroid cells. Interestingly, only the smallest
construct carrying 190 bp of the Wnt4 5′-flanking region
shows a strongly reduced activity in the FRTL-5 cells
(Figure 2A). These data indicate that the 5′-flanking re-
gion of Wnt4 is transcriptionally active in thyroid cells
and prompted us to further study the role of Pax8 in the
modulation of Wnt4 expression. Initially, we tested the ef-
fect of Pax8 transient expression on the −300 and −190
promoter regions by luciferase assays (Figure 2B). Specific-
ally, we performed transactivation assays in HeLa cells by
transfecting the reporter constructs 300Wnt4LUC and
190Wnt4LUC together with increasing concentration of
Pax8. As shown in Figure 2B, Pax8 is able to activate
transcription from the 300Wnt4LUC reporter in a dose
dependent manner but not from the smallest construct
190Wnt4LUC, suggesting that the region between -300 bp
and -190 bp upstream the translational start site of the
Wnt4 gene is required for Pax8 positive modulation. Sub-
sequently, to further confirm the ability of Pax8 to physic-
ally interact with the Wnt4 promoter region in vivo, we
performed chromatin immunoprecipitation (ChIP) assays
on genomic DNA from FRTL-5 cells. The cross-linked
chromatin was immunoprecipitated using a specific anti-
body against Pax8. The enrichment of the endogenous
Wnt4 region was monitored by PCR amplification usingspecific primers designed to amplify the region of Wnt4
between -300 bp and -190 bp required for Pax8 transcrip-
tional activation. The ChIP assay demonstrates that, in
agreement with the transactivation data, Pax8 is able to
bind in vivo the Wnt4 promoter (Figure 2C).
Identification of a Pax8 binding site on the Wnt4
proximal promoter region
The in silico analysis by the MatInspector software pre-
dicted two binding sites for Pax8 within the region span-
ning from -300 bp to -190 bp upstream the ATG of the
Wnt4 gene that we named A and B, respectively. Specif-
ically, site A was identified on the negative strand, while
site B was identified on the positive strand of the DNA
sequence, positioned on the rat promoter at -297 and
-211 bp from the ATG, respectively. The alignment of
the core sequence of the two putative Pax8 binding sites
shows a high grade of conservation among the species,
highlighting the potential relevance of these sites for
Wnt4 expression (Figure 3A).
To further characterize and verify the prediction ob-
tained by the MatInspector analysis, we designed two
oligo probes, containing the putative binding sites A
and B, and we performed gel mobility shift experiments.
Interestingly, the retarded band observed when the
FRTL-5 protein extract was incubated with oligo A
(Figure 3B, probe A, lane 2) is similar to that observed
in the positive control (Figure 3B, probe A, lane 4). In
contrast, the predicted binding site B could not be con-
firmed as a Pax8 binding site (Figure 3B, probe B).
Afterwards, we demonstrated by competition and
supershift assays that the shift observed when the
Figure 2 Pax8 activates transcription from the Wnt4 5′-flanking region. A) Transcriptional activity of Wnt4 5′-flanking genomic region. The
deletion reporter constructs were transfected into FRTL-5 and HeLa cells and the luciferase activity was determined. All the constructs have the
highest activity in thyroid cells and only the 190Wnt4LUC construct shows a strongly reduced activity. Data are expressed as the mean ± SD
(P < 0,0001); B) Pax8 activates transcription from the Wnt4 promoter region. HeLa cells were transiently transfected with 300Wnt4LUC and
190Wnt4LUC reporter constructs alone and in combination with increasing concentration (100 and 200 ng) of the expression vector encoding
Pax8 (CMV5-Pax8). The transcriptional activity was determined 48 h after transfection as the firefly over renilla luciferase activity. Data are expressed
as fold induction over the transcription obtained with 300Wnt4LUC and 190Wnt4LUC, whose values were set at 1. Data are from three independent
experiments, each performed in duplicate and are expressed as the mean ± SD (P < 0,005); C) Pax8 binds the Wnt4 promoter region in vivo. Chromatin
extracted from cross-linked FRTL-5 cells was immunoprecipitated with an unrelated antibody or for Pax8. The immunoprecipitates were analyzed by
PCR with oligonucleotides able to amplify the region between -300 bp and -190 bp of the 5′flanking region of the Wnt4 gene.
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a specific interaction (Figure 3B). All together, these re-
sults demonstrate that Pax8 is able to specifically bind
to the sequence identified in this study.
To demonstrate the functional relevance of Pax8 bind-
ing to the Wnt4 promoter, we generated a deletion mutant
(260Wnt4LUC) that lacks the sequence predicted to be
recognized by Pax8. Luciferase reporter constructs
300Wnt4LUC and 260Wnt4LUC were transiently trans-
fected into FRTL-5 cells and the luciferase activity was
measured 48 h later. As shown in Figure 3C, transfection
of the 300Wnt4LUC construct produces high levels ofluciferase activity, while the selective deletion of Pax8
binding site results in a reduced activity of the
260Wnt4LUC construct (about 50% reduction), indicat-
ing that the binding site A that we have identified is ne-
cessary for Wnt4 full promoter activity.
Wnt4 is responsible for the maintenance of the epithelial
phenotype
Recently, Wnt4 was demonstrated to be essential for
normal conversion of metanephric mesenchyme to the
epithelia of the nephron [6]. This evidence prompted us
to investigate the involvement of Wnt4 in the EMT
Figure 3 (See legend on next page.)
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Figure 3 Wnt4 5′-flanking region contains a binding site for Pax8. A) Graphic output of the sequence analysis showing the conservation in different
species of the core consensus sequences (in bold) of Pax8 binding sites. The sequence alignment was obtained using whole genome comparative analysis
of the VISTA browser; B) Electromobility shift assays for Pax8 binding to putative recognition motifs in the Wnt4 promoter. Left panel, 32P-labeled oligo
probes A and B were challenged with total protein extracts prepared from FRTL-5 cells (lane 2). Protein extracts of HeLa (lane 3) and Pax8-transfected HeLa
cells (lane 4) were used as negative and positive control, respectively. Middle panel, the specificity of the complex observed with the FRTL-5 extract and
probe A was tested by competition analysis, using increasing amount (from 25 to 100-fold molar excess) of unlabeled wild-type oligo A or mutated in the
core sequence. Right panel, the FRTL-5 protein extract was incubated with the antibody against Pax8 or tubulin (as negative control), in a supershift EMSA
with labeled probe A; C) Pax8 binding site A is necessary for the transcriptional activity of Wnt4 promoter. The deletion constructs 300Wnt4LUC and
260Wnt4LUC were transfected into FRTL-5 thyroid cells and the luciferase activity was determined. Data are from three independent experiments, each
performed in duplicate and are expressed as the mean ± SD (P < 0,05).
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inhibited Wnt4 expression in FRTL-5 by means of RNA
interference and we analyzed by qRT-PCR the expres-
sion level of some EMT markers. Seventy-two hours
after siRNA transfection, we analyzed the expression
level of Wnt4, E-cadherin (E-cad) as an epithelial
marker and α-Smooth muscle actin (α-SMA) and
Vimentin (VIM) as mesenchymal markers. By qRT-PCR
we show that upon Wnt4 knockdown, the mRNA level
of E-cad is reduced while the expression level of the
mesenchymal markers α-SMA and VIM is upregulated
with respect to the FRTL-5 transfected with siCtrl-
(Figure 4A).Figure 4 Wnt4 expression correlates with the maintenance of the epith
analysis was performed on total RNA prepared from FRTL-5 cells transfected w
measured; B) Effect of Wnt4 overexpression on EMT of thyroid cells. qRT-PCR
31 and 35 and from FRTL-5 stable transfected with the empty vector. The exp
the mean ± SD (P < 0,05). On the right, protein levels were evaluated by imm
hybridization with GAPDH assessed the protein uniform loading integrity. FolOur findings demonstrate that reduced levels of Wnt4
correlate with EMT, suggesting a relevant role of this
gene in the maintenance of the epithelial phenotype of
FRTL-5 thyroid cells. To better clarify the involvement
of Wnt4 in this process, we generated FRTL-5 cells
overexpressing Wnt4 and we analyzed, by qRT-PCR and
Western blot, the expression level of the EMT markers
above mentioned. The stable overexpression of Wnt4 is
able to revert the mesenchymal phenotype; in fact, the
upregulation of Wnt4 determines a stabilization of E-
cad and a reduction of α-SMA and VIM (Figure 4B).
The apparent difference between mRNA and protein
level of VIM in our opinion could be due to theelial state. A) Effect of Wnt4 silencing on EMT of thyroid cells. qRT-PCR
ith siWnt4 or siCtrl-. The expression of E-cad, α-SMA and VIM was
analysis was performed on total RNA prepared from FRTL-5-Wnt4 clones
ression of E-cad, α-SMA and Vim was measured. Data are expressed as
unoblotting analysis using Wnt4, E-cad and VIM antibodies. The
d represents the quantification of protein levels normalized with GAPDH.
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dance, underlining the importance of post-translational
mechanisms controlling gene expression.
Wnt4 is down-regulated in human thyroid cancer cells
and its overexpression inhibits cellular migration
We analyzed the expression level of Wnt4 in human
thyroid cancer cell lines by qRT-PCR. In particular, we
analyzed the WRO, Cal62, FB2 and BCPAP cells derived
from follicular, anaplastic and papillary thyroid carcin-
oma, and a pool of six normal thyroid (N.T.) tissues as
control. As expected, in all the thyroid cancer cell lines
the expression level of Wnt4 is strongly reduced with re-
spect to normal thyroid (Figure 5), indicating that a
down-regulation of Wnt4 occurs in thyroid carcinoma.
Interestingly, also the expression of PAX8 is significantly
down-regulated in the same cell lines. The same result
has been obtained by Western blot analysis (Figure 5,
bottom panel). To further evaluate the involvement of
Wnt4 in thyroid tumors we overexpressed Wnt4 in theFigure 5 Pax8 and Wnt4 expression in human thyroid cancer
cell lines. Wnt4 and Pax8 expression was measured by qRT-PCR in
four human thyroid cancer cell lines: WRO from follicular thyroid
cancer, Cal62 from anaplastic thyroid carcinoma, FB2 and BCPAP
from papillary thyroid carcinoma. RNA from six non-pathological
thyroids (N.T.) was used as control. Quantitative real-time PCR was
carried out in triplicate as described in Materials and Methods.
Glyceraldehyde 3-phosphate dehydrogenase was used as reference
gene; results are reported as 2-ΔCt. Data are expressed as the mean ±
SD (P < 0,05). The bottom panel shows the total protein extracts of
FRTL-5 cells (used as normal thyroid) and human thyroid cancer cells
WRO, Cal62, FB2 and BCPAP separated on SDS-PAGE and subjected
to Western blot analysis with specific antibodies as indicated in the
panel. The hybridization with GAPDH assessed the protein uniform
loading integrity. Fold represents the quantification of protein levels
normalized with GAPDH.BCPAP cell line and we selected a BCPAP-Wnt4 mass
population. In parallel, we also generated a control
mass population transfected with the backbone vector
(BCPAP-pCEFL).
To study whether elevated levels of Wnt4 might have a
role in cell migration, we performed wound-healing assays
using the two mass populations described above. The
assay shows that after 12 hours the area of the wound is
completely recovered by the BCPAP parental and the
BCPAP-pCEFL cells. At difference, the motility of the
BCPAP-Wnt4 cells appears strongly impaired, suggesting
that Wnt4 overexpression significantly reduces the migra-
tion ability of human papillary thyroid cells (Figure 6).
Discussion
In the last few years many data revealed that a set of tran-
scriptional regulators, unique to the thyroid follicular cell
type, has been identified as responsible for thyroid-specific
gene expression. It comprises three transcription factors:
TTF-1, Foxe-1 and Pax8, each of which is expressed also
in cell types different from the thyroid follicular cells. Al-
beit, the specific combination of these factors is unique to
the thyroid hormone producing cells, strongly suggesting
that such combination plays an important role in the dif-
ferentiation process of these cells [30,31]. In particular, the
transcription factor Pax8 is a master gene for thyroid
differentiation, being necessary for the transcriptional
activation of all the known differentiation markers [32].
Moreover, Pax8 knockout mice show a severe thyroid
phenotype [14] and are unfertile [24,25]. In humans, pa-
tients carrying mutations in the Pax8 gene suffer from
congenital hypothyroidism [16,33].
Together with the transcription factor Pax2, Pax8 is
also a central regulator of both nephron differentiation
and branching morphogenesis in the developing kidney.
Both transcription factors are necessary and sufficient
for the formation of the pronephros and all subsequent
kidney structures, regulating key target genes involved in
pro/mesonephros formation [20,34]. In parallel, a co-
operative role for Pax2 and Pax8 in metanephric branch-
ing morphogenesis and nephron differentiation has been
uncovered [34].
In thyroid, Wnt4 has been recently demonstrated to
be a key player in Ras-mediated transformation of epi-
thelial cells. Moreover, our recent data suggested that
Wnt4 could be a direct target of Pax8 in FRTL-5 rat thy-
roid cells [13].
In this study, we show that Pax8 modulates the ex-
pression of Wnt4 at the transcriptional level. By EMSA,
ChIP and transfection assays, we demonstrate that Pax8
directly binds to the Wnt4 promoter region and acti-
vates transcription from it.
It is well known that TSH is the main regulator of thy-
roid differentiation [26]. Its role in this process has been
Figure 6 Wnt4 overexpression in human papillary thyroid cancer cells inhibits cellular migration. Wound healing migration assay for
BCPAP, BCPAP-pCEFL and BCPAP-Wnt4 was performed. The healing of the wounds by migrating cells was imaged at time 0 h, 4 h, 8 h and 12 h
(upper panel). BCPAP-Wnt4 cells migrate significantly less than BCPAP and BCPAP-pCEFL cells. Wound closure is expressed as the percentage of
the initial wound diameter at 0 h. Data are expressed as the mean ± SD (P < 0,01, right panel).
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sion of several thyroid-specific genes, such as Tg, TPO,
TSHR and NIS has been shown to be modulated by
TSH/cAMP. In the past, we demonstrated that in PCCl3
cells, TSH regulates the expression of Tg and Pax8 at
the transcriptional level by a cAMP-mediated mechan-
ism [26]. Here, we show that in FRTL-5 rat thyroid cells
also the expression of Wnt4 is under the control of TSH
and that this control is likely mediated by Pax8. In fact,
TSH deprivation causes a significant reduction of both
Pax8 and Wnt4 and the kinetic of induction of Wnt4 ex-
pression upon TSH stimulation well correlates with that
of Pax8. Interestingly, it has been demonstrated that
TSH supports maintenance of thyroid follicular integrity
in primary cultured pig thyrocytes, stabilizing E-
cadherin at the cell surface and preventing its acceler-
ated turnover to support the maintenance of thyroid fol-
licular integrity [36]. Therefore, we would like to
propose that TSH promotes and ensures the mainten-
ance of the architecture and integrity of the follicles also
regulating the expression of Wnt4. Of course, this is cur-
rently a hypothesis that requires further investigations
and experimental validations.
The epithelial-mesenchymal transition (EMT) is an
orchestrated series of events in which cell-cell and cell-
extracellular matrix (ECM) interactions are altered to
release epithelial cells from the surrounding tissue. The
cytoskeleton is reorganized to confer the ability to move
through a three-dimensional ECM, and a new transcrip-
tional program is induced to maintain the mesenchymal
phenotype. Induction of EMT can compromise the
mechanical and physiological integrity of the tissue, and
inappropriate induction of this process can have disas-
trous consequences. EMT also acts in tumor progression
by providing increased resistance to apoptotic agents[37,38] and by producing supporting tissues that en-
hance the malignancy of the central tumor.
Recently, Wnt4 has been demonstrated to be critical for
mesenchyme – epithelium transition of the epithelia of
the nephron [6]. In agreement with these data, we report
in this manuscript that in FRTL-5 thyroid cells Wnt4 is
involved in the maintenance of the epithelial phenotype.
In fact, the EMT induced by Wnt4 down-regulation can
be reverted in the cellular model system that stable over-
expresses Wnt4. These results allow us to suggest that in
thyroid cells, as in kidney cells, the expression of Wnt4
correlates with the integrity of the epithelial phenotype.
Many publications emphasize the role of the Wnt/β-
catenin pathway in thyroid cancer. Recently, it has been
shown that Wnt4 down-regulation is necessary for the
progression of thyroid epithelial tumors toward a fully
malignant phenotype [12]. Moreover, it has been exten-
sively demonstrated that a progressive decrease of Pax8
level occurs in thyroid tumors from follicular adenoma
to differentiated carcinoma and then to anaplastic car-
cinoma, which parallels the progressive dedifferentiation
and increasing malignancy of thyroid tumors [39]. Here,
we show that in human thyroid cancer cell lines, Wnt4
and PAX8 mRNA levels are strongly reduced. Moreover,
the overexpression of Wnt4 in human papillary cancer
cells is able to affect the stabilization of the epithelial
state and to inhibit cellular migration.
In the future, it will be interesting to further clarify the
role of Wnt4 in thyroid differentiation and tumorigenesis.
Conclusions
The results presented in this study demonstrate that the
transcriptional factor Pax8 is involved in the transcriptional
modulation of Wnt4 gene expression in differentiated thy-
roid cells. Furthermore, we show that a reduced expression
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phenotype and that Wnt4 overexpression in thyroid cancer
cells is able to inhibit cellular migration. Taken together,
our data highlight a potential intriguing role of Wnt4 in the
context of the thyroid cell.
Methods
Protein extracts and Western blot
Cells were washed twice with ice cold PBS and lysed in
a buffer containing 50 mM HEPES (pH 7.5), 150 mM
NaCl, 5 mM EGTA (pH 7.8), 10% glycerol, 1% triton X-
100, 1 mM DTT and 1 mM PMSF. Protein concentra-
tion was determined using the Bio-Rad protein assay
(Bio-Rad Laboratories, Inc., Hercules, CA). For Western
Blot analysis, proteins were separated by SDS-PAGE.
Gels were blotted onto Immobilon P (Millipore Corp.,
Bedford, MA) for 3 h, and the membranes were blocked
in 5% nonfat dry milk for 1 h at room temperature. The
antibodies used for immunoblotting were: Wnt4
(Mouse anti-WNT4, Invitrogen), Pax8 (kindly provided
by Prof. R. Di Lauro), vimentin, E-cadherin, GAPDH
(Santa Cruz Biotechnology, Inc.). Subsequently, the filters
were developed using an enhanced chemi-luminescence
detection method (Pierce Chemical Co., Madison, WI)
according to the manufacturer’s directions.
Indirect immunofluorescence
FRTL-5 cells, grown on 12 mm diameter glass coverslips,
were fixed with pre-chilled methanol at -20°C for 5 min,
permeabilized for 10 min in 0.2% triton X-100 in PBS, and
then rinsed with phosphate-buffered saline (PBS) to prepare
them for immunostaining. Briefly, the cells were subse-
quently blocked with washing buffer containing 0.5% BSA
for 1 h and treated with rabbit policlonal anti-WNT4
(Wnt4 antibody, Novus) O/N and then with Alexa Fluor®
594-conjugated secondary antibody (Invitrogen) for 30 min,
followed by treatment with mouse monoclonal anti-PAX8
(BIOCARE MEDICAL) for 1 h and finally by an Alexa
Fluor® 488-conjugated secondary antibody (Invitrogen).
Several washes were interposed between the different anti-
bodies incubations. Cell nuclei were identified by Hoechst
staining. The coverslips were mounted on a microscope
slide using a 70% (v/v) solution of glycerol in PBS and
images were collected as previously described [40].
Promoter constructs and plasmids
Specific proximal promoter fragments of rat Wnt4 gene
were amplified by PCR. The 3100Wnt4LUC was sub-
cloned into MluI/BglII sites of the pGL3basic vector
(Promega, Madison, WI), while all the other constructs
were subcloned into XhoI/HindIII of the same vector.
Wnt4 cDNA (NCBI Reference Sequence NM_005923)
was kindly provided by G. De Vita. The CMV-Pax8 con-
struct was already described [41].Cell culture and transfection assays
Rat thyroid follicular FRTL-5 cells were maintained in
Coon’s modified F12 medium (EuroClone, MI, Italy) as
previously described [42].
The starvation medium consisted of Coon’s modified
Ham’s F12 medium supplemented only with 0.2% newborn
calf serum (HyClone, Logan, UT). TSH treatment was per-
formed by the addition of 1 mU/ml TSH (Sigma-Aldrich,
St. Louis, MO) to the culture medium at 3 h or 24 h after
starvation.
HeLa, WRO, FB2, Cal62 and BCPAP cells were grown
in DMEM (EuroClone) supplemented with 10% (v/v)
fetal bovine serum (HyClone, Logan, UT).
Transfections and luciferase assays were carried out as
previously described [43].
ChIP assay
ChIP was performed as previously described [13].
Precleared chromatin from FRTL-5 cells was incubated
with 1 μg of affinity-purified rabbit polyclonal antibody
anti-Pax8 (kindly provided by Prof. R. Di Lauro), unrelated
antibody (α Tubulin, Santa Cruz) or no antibody and
rotated at 4°C for 16 h. The immunoprecipitated DNA
was analyzed by PCR using the following Wnt4 primers:
5′- GATCCAGAAGCGAGGTTTCGGAT -3′ and 5′-
AACCTAGTCACTAGCGCTCGGG-3′.
Electrophoretic mobility shift assay (EMSA)
Double-strand oligonucleotides were labeled with γ-32P
ATP and T4 polynucleotide kinase and used as probes. The
binding reactions were carried out in a buffer containing
20 mM Tris–HCl (pH 7.6), 75 mM KCl, 1 mM dithiothrei-
tol, 10% glycerol, 1 mg/ml BSA, and 3 mg/ml polydeoxyi-
nosinic deoxycytidylic acid. After 30 min of incubation at
room temperature, free DNA and DNA-protein complexes
were resolved on a 6% non-denaturating polyacrylamide gel
and visualized by autoradiography.
The oligonucleotides used in the competition assay
and the antibodies used in the supershift experiments
were incubated with the protein extract for 20 min be-
fore adding the probe.
Oligonucleotides were: probe A, 5′-GCGGGTCCAGC
GGCGCGGGACACCCCCC-3′ and probe B, 5′-TCCGCC
GCCACCGCCGCATCCCGGCTCTG-3′. The oligonucleo-
tide mutated in the core sequence was: 5′-GCGGGTCC
AGCGGATATGGACACCCCCCC-3′.
RNA interference
FRTL-5 cells were plated (8×104 cells) in a 24-well plate
and were transfected in triplicate with 50 nM rat Wnt4
siRNA (Ambion, Life Technologies Ltd, UK), 50 nM
siGENOME Non-Targeting #3 (Dharmacon, Lafayette,
CO), or with 100 nM Pax8 siGENOME siRNA or
siGENOME Non-Targeting #3 (DHARMACON) as
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following the manufacturer’s protocol.
RNA extraction, cDNA synthesis and quantitative RT-PCR
Total RNA was prepared using TRIzol Reagent (Invitro-
gen, San Diego, CA) according to the manufacturer’s
directions. Total RNA (1 μg) was retrotranscribed using
the iScript cDNA Synthesis kit (Bio-Rad Laboratories).
Real-time PCR analysis was performed using an iCycler-
iQ real-time detection system and SYBR green chemistry
(Bio-Rad Laboratories).
Reactions were carried out in duplicate in three inde-
pendent experiments. For each gene, values are means ±
SD of three independent experiments, normalized by the
expression of an housekeeping gene, and expressed as a
percentage of the value measured in parental FRTL-5 or
BCPAP cells. To calculate the relative expression levels,
we used the 2−DDCT method [44].
Wound-healing assay
Confluent BCPAP, BCPAP-pCEFL and BCPAP-Wnt4
cells plated on tissue culture dishes were wounded by
manual scratching with 10-μl pipette tip, washed with
PBS and incubated at 37°C in complete media. At the
indicated time points, phase contrast images at specific
wound size were captured.
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